Search Results for "activate"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for activate. Results 1241 to 1250 of 1329 total matches.
Comparison Table: Some Drugs for Migraine Prevention in Adults (online only)
The Medical Letter on Drugs and Therapeutics • Jun 12, 2023 (Issue 1678)
-drug antibodies with in vitro neutralizing
activity have developed; clinical
significance unknown ...
View the Comparison Table: Some Drugs for Migraine Prevention in Adults
Med Lett Drugs Ther. 2023 Jun 12;65(1678):e100-2 doi:10.58347/tml.2023.1678c | Show Introduction Hide Introduction
Intravenous Acetaminophen/Ibuprofen (Combogesic IV)
The Medical Letter on Drugs and Therapeutics • Apr 29, 2024 (Issue 1701)
impairment and
is contraindicated in patients with severe hepatic
impairment or severe active liver disease ...
The FDA has approved Combogesic IV (Hikma), an IV
solution containing acetaminophen and ibuprofen, to
treat mild to moderate pain (alone) or moderate to
severe pain (in combination with an opioid) in adults
when IV analgesia is considered clinically necessary.
Single-drug IV solutions containing ibuprofen
(Caldolor) and acetaminophen have been available in
the US for years.
Med Lett Drugs Ther. 2024 Apr 29;66(1701):68-9 doi:10.58347/tml.2024.1701c | Show Introduction Hide Introduction
Vadadustat (Vafseo) for Anemia of Chronic Kidney Disease
The Medical Letter on Drugs and Therapeutics • Feb 17, 2025 (Issue 1722)
levels of HIF may stimulate cancer growth;
use of vadadustat is not recommended in patients
with active ...
The FDA has approved the hypoxia-inducible factor
prolyl hydroxylase inhibitor (HIF-PHI) vadadustat
(Vafseo – Akebia) for oral treatment of anemia due
to chronic kidney disease (CKD) in adults who have
been on dialysis for at least 3 months. Vadadustat is
the second HIF-PHI to be approved in the US for this
indication; daprodustat (Jesduvroq) was approved
earlier, but it was withdrawn from the US market in
2024 for commercial reasons.
Med Lett Drugs Ther. 2025 Feb 17;67(1722):27-9 doi:10.58347/tml.2025.1722b | Show Introduction Hide Introduction
Cancer Screening
Treatment Guidelines from The Medical Letter • Dec 01, 2012 (Issue 124)
following onset of sexual activity.
Almost 50% of women ages 20-24 have HPV infection2;
however ...
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may
improve outcomes. Screening tests for some common
cancers are reviewed below.
Vaccines for Travelers
The Medical Letter on Drugs and Therapeutics • Nov 19, 2018 (Issue 1560)
vaccines and, depending on their
destination, duration of travel, and planned activities,
may also ...
Persons planning to travel outside the US should be
up to date on routine vaccines and, depending on their
destination, duration of travel, and planned activities,
may also receive certain travel-specific vaccines.
Tickborne encephalitis and dengue vaccines, which
are not available in the US, are reviewed in a separate
article available online. Detailed advice for travel to
specific destinations is available from the Centers for
Disease Control and Prevention (CDC) at www.cdc.gov/travel/destinations/list. Recommendations for
administration of vaccines as part of routine...
Drugs for Chronic Heart Failure
The Medical Letter on Drugs and Therapeutics • Jun 14, 2021 (Issue 1626)
, which has vasodilatory
activity, may cause more hypotension than metoprolol
or bisoprolol. Beta ...
Among patients with chronic heart failure, those with
a left ventricular ejection fraction (LVEF) ≤40% are
considered to have heart failure with reduced ejection
fraction (HFrEF). Patients with a LVEF ≥50% are
considered to have heart failure with preserved ejection
fraction (HFpEF). Those with a LVEF of 41-49% are an
intermediate group more similar to patients with HFpEF.
Drugs for Anxiety Disorders
The Medical Letter on Drugs and Therapeutics • Aug 07, 2023 (Issue 1682)
are stopped abruptly. Onset of withdrawal depends
on the drug’s half-life and the presence of active ...
Anxiety disorders (generalized anxiety disorder,
panic disorder, social anxiety disorder, and various
phobias) are the most common form of psychiatric
illness. They can be treated effectively with cognitive
behavioral therapy (CBT) and/or pharmacotherapy.
Med Lett Drugs Ther. 2023 Aug 7;65(1682):121-8 doi:10.58347/tml.2023.1682a | Show Introduction Hide Introduction
Drugs for Psychotic Disorders
The Medical Letter on Drugs and Therapeutics • Dec 19, 2016 (Issue 1510)
-generation
antipsychotics except for paliperidone, which is the active
metabolite of risperidone). At doses ...
Oral antipsychotic drugs used for treatment of
schizophrenia, schizoaffective disorder, delusional
disorder, and other manifestations of psychosis or
mania are listed in Table 1. Parenteral
antipsychotic drugs used for treatment of these
disorders are listed in Table 2.
Drugs for Benign Prostatic Hyperplasia
The Medical Letter on Drugs and Therapeutics • May 02, 2022 (Issue 1649)
and urine storage (urgency, frequency, nocturia).
Activation of beta-3 receptors in the bladder causes ...
About 60% of men ≥60 years old have clinically
relevant prostatic enlargement due to benign prostatic
hyperplasia (BPH). The goals of treatment are to
decrease lower urinary tract symptoms and to prevent
disease progression and complications such as acute
urinary retention. The American Urologic Association's
guidelines for treatment of BPH were recently updated.
Drugs for Vomiting Caused by Cancer Chemotherapy
The Medical Letter on Drugs and Therapeutics • Dec 24, 1993 (Issue 912)
OF U.S. AND INTERNATIONAL COPYRIGHT LAWS
increases in serum aminotransferase activity can occur ...
Several currently available antiemetic drugs can prevent vomiting caused by cancer chemotherapy. Anticancer drugs that cause vomiting are listed in the table below.